Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02079935
Other study ID # 2013/344
Secondary ID 2013/1871
Status Completed
Phase N/A
First received
Last updated
Start date March 2014
Est. completion date January 31, 2019

Study information

Verified date March 2019
Source Norwegian School of Sport Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

"Eating disorders" includes anorexia nervosa, bulimia nervosa, binge eating and other specified feeding or eating disorder (OSFED). Common to all is the intensively occupation to control food intake, body image and body weight. Most people with this kind of disorder don't reach for professional help, or there may be more than 4 years before they do. Cognitive behavior therapy is the foremost method of treatment of eating disorders, but up to 30-50% of the patients don't respond to this. The investigators find it important to identify science based alternatives of therapy, as this may reduce the health concern, and broaden the choice of therapy methods. A former study by Sundgot-Borgen et al in 2002, found guided physical activity to reduce symptoms of bulimia nervosa just as good as the traditional cognitive therapy.

The primary objective of the project is to see whether the combination of physical exercise and dietary therapy is more effective in treating eating disorders, than cognitive therapy.

Secondly, the investigators want to see whether there are any differences with regard to the individual satisfaction of treatment method, and to associated costs. Interviews with a sufficient number of participants from the PED-t arm to meet data saturation criteria, and all theraphists in the new treatment offer, will give uniqe insight to experiences with the treatment method and the delivery of treatment.


Description:

Subjects are recruited through primary doctors, social media and newspapers, and will be included continuously by screening interviews. There will be a randomization into two treatment groups (cognitive behavior, or physical activity and nutrition education) to be followed for 16 weeks. Each week includes one meeting of group therapy (90 minutes) and homework related to treatment, and for 4 weeks midway there will be two therapy meetings pr week (a total of 20 meetings). Post tests are planned at week 17, and at 6, 12, and 24 months after treatment.

Participants reqruited during ongoing treatment groups are placed on a waitlist, serving as controls to the treatment groups.


Recruitment information / eligibility

Status Completed
Enrollment 128
Est. completion date January 31, 2019
Est. primary completion date January 31, 2019
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Women,

- BMI 17,5-35,

- Age of 18-40 years,

- DSM-5 criteria of bulimia nervosa,

- DSM-5 criteria of Binge eating disorder

- Living nearby Norwegian School of Sports Sciences, NSSS, in Oslo (Norway)

Exclusion Criteria:

- Age <18 and >40 years

- BMI <17,5 and >35

- Pregnancy

- Competing/experienced athlete

- Anorexia nervosa

- Currently, or during the past 2 years, in active treatment with cognitive therapy

- Other personality disturbances

- Suicidality

Study Design


Intervention

Behavioral:
Cognitive Behaviour Therapy
Following group-modified protocol for cognitive behavioral therapy, CBT, first described by Fairburn 2008, modified by Modum Bad, Norway.
Physical Activity and Dietary Therapy
Guided physical activity and dietary therapy, to (re-)introduce a more healthy lifestyle and help stabilizing a healthy weight. A detailed manual will be published.

Locations

Country Name City State
Norway Norwegian School of Sports Sciences Oslo

Sponsors (3)

Lead Sponsor Collaborator
Norwegian School of Sport Sciences The Norwegian Women´s Public Health Association, University of Tromso

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Sundgot-Borgen J, Rosenvinge JH, Bahr R, Schneider LS. The effect of exercise, cognitive therapy, and nutritional counseling in treating bulimia nervosa. Med Sci Sports Exerc. 2002 Feb;34(2):190-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Change in muscular strength Status of 1 repetition maximum, 1RM, muscular strength in squats, bench press and seated row Pretest (week 0), post-test (week 17) and at 6, 12 and 24 months after treatment
Other Change in cardiovascular endurance CPET: with the use of modified Balke Treadmill performance evaluation test, The Borg scale (Borg, 1982) Pre-test in week 0, Post-tests ( week 17), and at 6, 12 and 24 months after intervention.
Other Change in bone mineral density DXA (Dual-energy X-ray absorptiometry) Pre-test in week 0, Post-test (week 17) and 6, 12, and 24 months post-treatment
Other Change in body weight and bodycomposition DXA (dual-energy x-ray absorptiometry) (weekly weight registration will also be kept in each arm of treatment) Pre-test and post-test (week 17) and at 6,12,18 and 24 months post-treatment
Other Change in nutritional status Blood test to identify nutritional status of iron, folate, cholesterol and triglycerides, ApoA, ApoB and vitamin-D, folic acid Pre-test, in week 8 of treatment, post-test (week 17) and at 6,12,18 and 24 months post-treatment
Other Change in hormonal status Blood test to evaluate hormonal status of estradiol, progesterone, CTX, P1nP, insulin, leptin, TSH, T3, T4, FSH, LH, cortisol Pre-test, week 8 of treatment, post-test (week 17) and at 6,12,18 and 24 months post-treatment
Other Change in dietary and nutritional intake 24 hour recall interview: interview on the intake of food and beverage during the past 24 hours. Pre-test, each 3rd week in treatment (a total of 5 interviews), post-test (week 17), and post-treatment (6,12, and 24 months post-treatment)
Other Change in physical activity level Wearing a GT3X-BT actigraph accelerometer for 7 consecutive days and making notes on daily activity in 30 minutes intervals Pre-test in week 0, Post-test (week 17) and 6, 12, and 24 months post-treatment
Other Interview: measure and explore patients experienced treatment satisfaction and outcome/benefits with PED-t. Qualitative approaches, such as in-depth interviews, will give additional insights into ED-patients' perspectives, notably experiences and satisfaction with the treatment. A sufficient number of participants to meet data saturation criteria are qualitatively interviewed.
Data are analyzed in four steps within the framework of systematic text condensation (Malterud 2012).
Post treatment
Other Interview: What are the theraphists experiences of their contribution to the PED-t program Qualitative approaches, such as in-depth interviews, will give additional insights into the therapists' perspectives and experiences on delivering a new treatment offer for eating disorder.
Data are analyzed in four steps within the framework of systematic text condensation (Malterud 2012).
Post treatment
Other Interview: What are the experiences of the participants who drop out of the PED-t program? Data are analyzed in four steps within the framework of systematic text condensation (Malterud 2012). Post treatment
Primary Effectiveness of treatment, evaluated through the change in symptoms of eating disorder Change in ED-symptoms are evaluated through screening and surveys: EDE-questionaire (Episodes of binge eating, episodes of purging, concern for body weight and appearance)(Fairburn, 2008), Clinical Impairment Assessment (CIA) (Fairburn, 2008), Eating Disorder Inventory-3 (EDI) (Garner, 2004), Eating Disturbance Scale (EDS-5) (Rosenvinge et al., 2000), DSM-5 (APA, 2013) Pre-test in week 0, Post-tests (week 17), and at 6, 12, and 24 months after intervention.
Secondary Expectations of treatment method for eating disorders Interview on the expectations the patients have to the specified treatment method of eating disorders (arm of intervention) EPDEX (Clinton 2001) Pre-test
Secondary Experiences of the treatment method for eating disorders Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention), EPDEX (Clinton 2001) Post-test (week 17)
Secondary Associated cost with treatment method Calculation of the directly and indirectly cost related to treatment method Pre-test
Secondary Associated cost with treatment method Calculation of the directly and indirectly cost related to treatment method Post-test (week 17)
Secondary Associated cost With treatment method Calculation of the directly and indirectly cost related to treatment method Post-test (by 6th month post-treatment)
Secondary Associated cost With treatment method Calculation of the directly and indirectly cost related to treatment method Post-test (by 12th month post-treatment)
Secondary Associated cost with treatment method Calculation of the directly and indirectly cost related to treatment method Post-test (by 24th month post-treatment)
Secondary Global measurement of general psychopathology Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test Pre-treatment
Secondary Global measurement of general psychopathology Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test Post-treatment (week 17)
Secondary Global measurement of general psychopathology Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test Post-treatment (by the 6th month post-treatment)
Secondary Global measurement of general psychopathology Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test Post-test (by 12th month post-treatment)
Secondary Global measurement of general psychopathology Beck's Anxiety Inventory (BAI), Beck Depression Inventory (BDI), QoL (Diener), Utrecht Coping List, Resilience Scale for Adults, the outcome rating scale (ORS), the three-factor eating questionnaire (TFEQ), Binge eating Scale (BES), Cantril's Ladder, Exercise dependency test, compulsice exercise test Post-test (by 24th month post-treatment)
Secondary Group climate coerciveness scale from Therapeutic Factor Inventory (Lese & MacNair-Semands, 2000). week 1-16
Secondary Working AIliance Working AIliance Inventory (Horwath & Greenberg, 1989) week 1-16
Secondary Experiences of the treatment method for eating disorders Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention) (Clinton 2001) Post-test (6 months)
Secondary Experiences of the treatment method for eating disorders Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention) (Clinton 2001) Post-test (by 12th month post-treatment)
Secondary Experiences of the treatment method for eating disorders Interview on the experiences the patients have to the specified treatment method of eating disorders (arm of intervention) (Clinton 2001) Post-test (by 24th month post-treatment)
Secondary Change in eating disorder behavior and cognitions related to body figure and bodyweight Evaluation after each therapy session on progress in reducing eating disordered behaviour (binging and purging) and on changes of cognitions on body figure and -weight Week 1-16 during treatment
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Withdrawn NCT02978742 - Evaluating and Implementing a Smartphone Application Treatment Program for Bulimia Nervosa and Binge Eating Disorder N/A
Withdrawn NCT00988481 - Topiramate Augmentation in Bulimia Nervosa Partial Responders Phase 4
Completed NCT00522769 - Cognitive Behavioral Therapy to Treat Bulimia Nervosa in Adolescents Phase 1/Phase 2
Completed NCT00184301 - A Comparison Study of Treatments Given to Patients With Concurrent Eating Disorder and Personality Disorder. N/A
Completed NCT00304187 - Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa Phase 2
Recruiting NCT04409457 - Self-Control in Bulimia Nervosa N/A
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Recruiting NCT05862389 - Study on the Mechanism of Eating Disorder
Recruiting NCT05937243 - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating N/A
Recruiting NCT05728021 - Smartphone-based Aftercare for Inpatients With Bulimia Nervosa N/A
Completed NCT03781921 - The Neural Bases of Emotion Regulation in Bulimia Nervosa
Completed NCT02553824 - FDA Approved Medication to Reduce Binge Eating and/or Purging Phase 1
Terminated NCT04041024 - Decision-making and Risk-taking in Bulimia N/A
Completed NCT04265131 - Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome? N/A
Recruiting NCT06431854 - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program N/A
Recruiting NCT02960152 - Periodontal Impact of Eating Disorders (the PERIOED Study) N/A
Completed NCT00916071 - Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders N/A
Terminated NCT00308776 - Cholecystokinin for Reducing Binge Eating in People With Bulimia Nervosa N/A